Cargando…
Significance of decoy receptor 3 (Dcr3) and external-signal regulated kinase 1/2 (Erk1/2) in gastric cancer
BACKGROUND: Decoy receptor 3 (DcR3), a member of the tumor necrosis factor receptor (TNFR) superfamily, is associated with anti-tumor immunity suppression. It is highly expressed in many tumors, and its expression can be regulated by the MAPK/MEK/ERK signaling pathway. The MAPK/MEK/ERK pathway has b...
Autores principales: | Yang, Donghai, Fan, Xin, Yin, Ping, Wen, Qiang, Yan, Feng, Yuan, Sibo, Liu, Bin, Zhuang, Guohong, Liu, Zhongchen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3459731/ https://www.ncbi.nlm.nih.gov/pubmed/22672288 http://dx.doi.org/10.1186/1471-2172-13-28 |
Ejemplares similares
-
TIPE Regulates DcR3 Expression and Function by Activating the PI3K/AKT Signaling Pathway in CRC
por: Zhong, Mengya, et al.
Publicado: (2021) -
‘Decoy’ and ‘non-decoy’ functions of DcR3 promote malignant potential in human malignant fibrous histiocytoma cells
por: TODA, MITSUNORI, et al.
Publicado: (2013) -
Decoy receptor 3 (DcR3) overexpression predicts the prognosis and pN2 in pancreatic head carcinoma
por: Zhou, Jian, et al.
Publicado: (2014) -
Decoy receptor 1 (DCR1) promoter hypermethylation and response to irinotecan in metastatic colorectal cancer
por: Bosch, Linda J.W., et al.
Publicado: (2017) -
Endoscopic DCR vs External DCR: What's Best in the Acute Setting?
por: Amadi, Arash J.
Publicado: (2017)